Navigation Links
ViroPharma Incorporated Reports Fourth Quarter and Full Year 2007 Financial Results
Date:2/27/2008

,219 3,184 24,265 9,853

Interest expense (1,434) - (4,395) (686)

-------- -------- -------- --------

Income before income tax expense 24,832 29,924 135,666 108,528

Income tax expense (benefit) 4,461 11,927 40,313 41,862

-------- -------- -------- --------

Net income $20,371 $17,997 $95,353 $66,666

======== ======== ======== ========

Basic net income per share $0.29 $0.26 $1.37 $0.97

======== ======== ======== ========

Diluted net income per share $0.25 $0.25 $1.21 $0.95

======== ======== ======== ========

Shares used in computing net

income per share

Basic 69,887 69,685 69,827 68,990

======== ======== ======== ========

Diluted 83,830 71,061 80,891 70,338

======== ======== ======== ========

Consolidated Balance Sheets: December 31,

-------------------

(in thousands) 2007 2006

-------- --------

Cash, cash equivalents and

short-term investments $584,328 $255,409

Working capital 594,403 266,443

Total assets 776,066 429,694

Total stockholders' equity 496,563 411,899


'/>"/>
SOURCE ViroPharma Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. ViroPharma to Present at the Maxim Group First Annual Growth Conference
2. ViroPharma to Present at the UBS Global Life Sciences Conference
3. ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results
4. ViroPharma Receives European Orphan Drug Designation for CAMVIA(TM)
5. ViroPharma to Present at the 26th Annual JP Morgan Healthcare Conference
6. ViroPharma Augments Senior Management
7. ViroPharma Provides Update on Vancocin(R)
8. Vincent J. Milano to Succeed Michel de Rosen as President and Chief Executive Officer of ViroPharma
9. Accuray Incorporateds CEO to Speak at UBS Global Life Sciences Conference
10. Accuray Incorporated to Report First Quarter Fiscal Year 2008 Financial Results
11. Aflac Incorporated to Release Third Quarter Results On October 23, 2007
Post Your Comments:
*Name:
*Comment:
*Email: